Earth Science Tech Reports Positive Progress on High Grade CBD (Cannabidiol) Rich Hemp Oil In Vitro Studies With DV Biologics

Life Science Investing News

Earth Science Tech Inc. (OTCMKTS:ETST) announced positive progress on its high grade CBD (Cannabidiol) Rich Hemp Oil in vitro studies on various human primary cells with DV Biologics.

Earth Science Tech Inc. (OTCMKTS:ETST) announced positive progress on its high grade CBD (Cannabidiol) Rich Hemp Oil in vitro studies on various human primary cells with DV Biologics.

As quoted in the press release:

In order to assure the public that ETST provides the best High Grade CBD (Cannabidiol) Rich Hemp Oil, we continue to focus on providing the public with sound scientific research and keeping the public informed on the progression of studies being done on our Hemp CBD products. DV Biologics, which is independently testing our ETST High Grade Hemp CBD Oil in vitro on various human primary cells, has informed us of the progression of studies being done. The goals of these studies are to test if ETST High Grade CBD Rich Hemp Oil serves as a neuroprotectant which may help with neurodegenerative disorders.

The use of human primary cells provides alternatives to using animal cells and performing animal studies which may not translate well into the human condition. It also allows for the specific targeted studies such as those described herein which will focus on reducing free radical formation and oxidative stress in the brain. Following these studies, in vivo studies will be needed to determine the ultimate effects of ETST CBD rich hemp oil serving as a neuroprotectant.

ETST has the world’s leading raw full spectrum, CO2 extracted, all natural, organic and scientifically formulated “High Grade CBD Rich Hemp Oil.” ETST is focused on the science, research and studies of its High Grade CBD Rich Hemp Oil as a nutraceutical and dietary supplement. ETST has 2 provisional patents and inventions with its CBD Rich Hemp Oil (CANNABIDIOL COMPOSITIONS INCLUDING MIXTURES AND USES THEREOF Patent Serial No. 62102538 and CANNABIDIOL COMPOSITIONS AN DUSES THEREOF Patent Serial No. 62061577). Additionally, ETST has a total of ten (10) new claims for its CBD Hemp Oil.

Dr. Rafael Gonzalez, vice president of research & development of DV Biologics, commented:

Testing compounds in vitro on human cells is difficult. We recently tested various concentrations of ETST High Grade CBD Hemp Oil on various cells to see which concentrations are toxic to cells and noted that the cells grow similarly in concentrations from 1-10 micromolar. This is exciting news as it shows that this product, ETST High Grade CBD Hemp Oil, may be used in varying concentrations without toxicity to different cell types. We are now ready to test whether ETST High Grade CBD Hemp Oil can stop or deter free radical formation that occurs in vitro with brain cells. In order to do so, we will use varying concentrations of ETST Hemp CBD Oil and induce oxidative stress on brain cells. We will then test the cells to see if the ETST Hemp CBD Oil reduces oxidative stress and free radical formation compared to a control cell type that has no ETST High Grade CBD Hemp Oil. We look forward to reporting the full study in the near future.

Click here to read the full Earth Science Tech Inc. (OTCMKTS:ETST) press release.

The Conversation (0)
×